ZimVie Inc. Logo

ZimVie Inc.

ZIMV

(1.5)
Stock Price

13,39 USD

-82.37% ROA

-73.96% ROE

-1.21x PER

Market Cap.

428.465.834,00 USD

60.74% DER

0% Yield

-63.84% NPM

ZimVie Inc. Stock Analysis

ZimVie Inc. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

ZimVie Inc. Fundamental Stock Analysis
# Analysis Rating
1 PBV

With a remarkably low PBV ratio (0.33x), the stock offers substantial upside potential at a bargain price.

2 DER

The stock has a reasonable amount of debt compared to its ownership (73%), suggesting a balanced financial position and a moderate level of risk.

3 Revenue Growth

Company's revenue has experienced consistent growth over the last three years, indicating a favorable financial trajectory and making it an attractive investment choice.

4 Net Profit Growth

This company's net profit has consistently grown over the past three years, showcasing a positive financial trend and making it an appealing investment opportunity.

5 Graham Number

The Graham number calculation reveals that this company's stock price is potentially underestimated, implying that it may be a promising investment option.

6 ROA

The stock's ROA (-13.51%) suggests that it's struggling to generate profits from its assets, making it a risky choice for investment.

7 Assets Growth

Company has experienced no growth in revenue over the past three years, suggesting limited profitability and making it a less desirable investment opportunity.

8 Dividend Growth

The company's dividend growth has been flat for the past three years, raising concerns for potential investors seeking reliable returns.

9 Dividend

No dividends from the company in the past three years raises doubts about its profitability for shareholders.

10 Buffet Intrinsic Value

The company's stock shows signs of being overvalued (-174) according to Warren Buffett's formula, indicating a potential downside as its market price exceeds its estimated intrinsic value.

11 ROE

Negative ROE (-12.08%) indicates poor financial performance, raising concerns about profitability and efficiency in utilizing shareholders' equity.

ZimVie Inc. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

ZimVie Inc. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Buy
3 RSI Sell
4 Stoch RSI Sell

ZimVie Inc. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

ZimVie Inc. Revenue
Year Revenue Growth
2018 1.099.100.000
2019 1.055.500.000 -4.13%
2020 912.400.000 -15.68%
2021 1.014.600.000 10.07%
2022 913.862.000 -11.02%
2023 811.488.000 -12.62%
2023 457.433.000 -77.4%
2024 467.244.000 2.1%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

ZimVie Inc. Research and Development Expenses
Year Research and Development Expenses Growth
2018 52.300.000
2019 55.600.000 5.94%
2020 49.200.000 -13.01%
2021 61.300.000 19.74%
2022 62.691.000 2.22%
2023 45.828.000 -36.8%
2023 26.162.000 -75.17%
2024 26.316.000 0.59%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

ZimVie Inc. General and Administrative Expenses
Year General and Administrative Expenses Growth
2018 0
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2023 0 0%
2024 0 0%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

ZimVie Inc. EBITDA
Year EBITDA Growth
2018 116.100.000
2019 112.500.000 -3.2%
2020 67.200.000 -67.41%
2021 56.100.000 -19.79%
2022 71.940.000 22.02%
2023 231.528.000 68.93%
2023 110.431.000 -109.66%
2024 27.276.000 -304.87%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

ZimVie Inc. Gross Profit
Year Gross Profit Growth
2018 716.400.000
2019 721.600.000 0.72%
2020 599.500.000 -20.37%
2021 628.800.000 4.66%
2022 613.076.000 -2.56%
2023 746.772.000 17.9%
2023 263.871.000 -183.01%
2024 269.180.000 1.97%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

ZimVie Inc. Net Profit
Year Net Profit Growth
2018 -460.400.000
2019 -27.900.000 -1550.18%
2020 -179.000.000 84.41%
2021 -95.300.000 -87.83%
2022 -63.881.000 -49.18%
2023 -20.356.000 -213.82%
2023 -393.282.000 94.82%
2024 -16.056.000 -2349.44%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

ZimVie Inc. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2018 -18
2019 -1 -1600%
2020 -7 83.33%
2021 -4 -100%
2022 -2 -50%
2023 -1 0%
2023 -15 100%
2024 -1 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

ZimVie Inc. Free Cashflow
Year Free Cashflow Growth
2018 113.700.000
2019 66.200.000 -71.75%
2020 47.700.000 -38.78%
2021 7.700.000 -519.48%
2022 -1.918.000 501.46%
2023 24.661.000 107.78%
2023 18.058.000 -36.57%
2024 1.778.000 -915.64%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

ZimVie Inc. Operating Cashflow
Year Operating Cashflow Growth
2018 162.000.000
2019 119.200.000 -35.91%
2020 86.000.000 -38.6%
2021 64.300.000 -33.75%
2022 24.628.000 -161.08%
2023 37.148.000 33.7%
2023 22.634.000 -64.12%
2024 3.036.000 -645.52%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

ZimVie Inc. Capital Expenditure
Year Capital Expenditure Growth
2018 48.300.000
2019 53.000.000 8.87%
2020 38.300.000 -38.38%
2021 56.600.000 32.33%
2022 26.546.000 -113.21%
2023 12.487.000 -112.59%
2023 4.576.000 -172.88%
2024 1.258.000 -263.75%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

ZimVie Inc. Equity
Year Equity Growth
2019 1.668.100.000
2020 1.490.500.000 -11.92%
2021 1.451.400.000 -2.69%
2022 758.604.000 -91.33%
2023 409.493.000 -85.25%
2023 710.199.000 42.34%
2024 394.099.000 -80.21%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

ZimVie Inc. Assets
Year Assets Growth
2019 2.110.400.000
2020 1.949.200.000 -8.27%
2021 1.826.700.000 -6.71%
2022 1.642.056.000 -11.24%
2023 1.205.345.000 -36.23%
2023 1.507.921.000 20.07%
2024 789.786.000 -90.93%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

ZimVie Inc. Liabilities
Year Liabilities Growth
2019 442.300.000
2020 458.700.000 3.58%
2021 375.300.000 -22.22%
2022 883.452.000 57.52%
2023 795.852.000 -11.01%
2023 797.722.000 0.23%
2024 395.687.000 -101.6%

ZimVie Inc. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
20.1
Net Income per Share
-12.83
Price to Earning Ratio
-1.21x
Price To Sales Ratio
0.78x
POCF Ratio
11.96
PFCF Ratio
17.26
Price to Book Ratio
1.08
EV to Sales
1.09
EV Over EBITDA
6.29
EV to Operating CashFlow
16.82
EV to FreeCashFlow
24.13
Earnings Yield
-0.83
FreeCashFlow Yield
0.06
Market Cap
0,43 Bil.
Enterprise Value
0,60 Bil.
Graham Number
64.44
Graham NetNet
-8.33

Income Statement Metrics

Net Income per Share
-12.83
Income Quality
-0.74
ROE
-0.74
Return On Assets
-0.45
Return On Capital Employed
0.08
Net Income per EBT
6.03
EBT Per Ebit
-1.13
Ebit per Revenue
0.09
Effective Tax Rate
0.17

Margins

Sales, General, & Administrative to Revenue
0
Research & Developement to Revenue
0.06
Stock Based Compensation to Revenue
0.04
Gross Profit Margin
0.7
Operating Profit Margin
0.09
Pretax Profit Margin
-0.11
Net Profit Margin
-0.64

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
1.3
Free CashFlow per Share
0.91
Capex to Operating CashFlow
0.3
Capex to Revenue
0.02
Capex to Depreciation
0.15
Return on Invested Capital
0.07
Return on Tangible Assets
-0.82
Days Sales Outstanding
46.72
Days Payables Outstanding
60.2
Days of Inventory on Hand
159.21
Receivables Turnover
7.81
Payables Turnover
6.06
Inventory Turnover
2.29
Capex per Share
0.39

Balance Sheet

Cash per Share
2,87
Book Value per Share
14,38
Tangible Book Value per Share
1.14
Shareholders Equity per Share
14.38
Interest Debt per Share
8.92
Debt to Equity
0.61
Debt to Assets
0.3
Net Debt to EBITDA
1.79
Current Ratio
1.94
Tangible Asset Value
0,03 Bil.
Net Current Asset Value
-0,12 Bil.
Invested Capital
545930000
Working Capital
0,13 Bil.
Intangibles to Total Assets
0.46
Average Receivables
0,07 Bil.
Average Payables
0,03 Bil.
Average Inventory
74533000
Debt to Market Cap
0.56

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

ZimVie Inc. Dividends
Year Dividends Growth

ZimVie Inc. Profile

About ZimVie Inc.

ZimVie Inc., a medical technology company, develops, manufactures, and delivers a portfolio of products and solutions designed to treat a range of spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It offers dental implant systems, prosthetic and abutment products, surgical instrumentation, and kits; bone grafts, barrier membranes, allografts, and collagen wound care products; intraoral scanners; and virtual treatment planning services, guided surgery solutions, CAD/CAM workflow systems, and patient-specific restorative components and intra-oral scanners, as well as spinal fusion implants and instrumentation for various spinal procedures, biologics, and bone healing technologies. The company also provides MIS solutions, such as Vital MIS and Timberline; and motion preservation solutions, including Mobi-C and The Tether. ZimVie Inc. was incorporated in 2021 and is headquartered in Westminster, Colorado.

CEO
Mr. Vafa Jamali
Employee
2.600
Address
10225 Westmoor Drive
Westminster, 80021

ZimVie Inc. Executives & BODs

ZimVie Inc. Executives & BODs
# Name Age
1 Ms. Ann Vu
SVice President & Chief Quality and Regulatory Affairs Officer
70
2 Mr. Vafa Jamali
President, Chief Executive Officer & Director
70
3 Sandra Schneider
Chief Accounting Officer
70
4 Ms. Heather Kidwell
Senior Vice President, Chief Legal, HR & Compliance Officer and Corporate Secretary
70
5 Mr. Indraneel Kanaglekar
Senior Vice President & Chief Commercial Officer
70
6 Mr. Steve Rondeau
Senior Vice President & Chief Information Officer
70
7 Mr. Richard J. Heppenstall
Executive Vice President, Chief Financial Officer & Treasurer
70

ZimVie Inc. Competitors

STERIS plc Logo
STERIS plc

STE

(2.8)
Smith & Nephew plc Logo
Smith & Nephew plc

SNN

(1.5)
NuVasive, Inc. Logo
NuVasive, Inc.

NUVA

(1.0)
CONMED Corporation Logo
CONMED Corporation

CNMD

(1.5)
Pulmonx Corporation Logo
Pulmonx Corporation

LUNG

(1.2)
SI-BONE, Inc. Logo
SI-BONE, Inc.

SIBN

(1.0)
NeuroPace, Inc. Logo
NeuroPace, Inc.

NPCE

(0.5)
CVRx, Inc. Logo
CVRx, Inc.

CVRX

(1.0)
Artivion, Inc. Logo
Artivion, Inc.

AORT

(0.5)
Heska Corporation Logo
Heska Corporation

HSKA

(1.0)
Inogen, Inc. Logo
Inogen, Inc.

INGN

(1.2)
Surmodics, Inc. Logo
Surmodics, Inc.

SRDX

(0.8)